29 April 2023>: Database Analysis
Clinical Course of 53 Previously Vaccinated Patients Admitted to the National Hospital in Warsaw, Poland with COVID-19 Between November 2021 and March 2022
Artur Zaczyński 1AB , Michał Hampel 1AB , Paweł Piątkiewicz 2AB* , Jacek Nasiłowski 3AB , Sławomir Butkiewicz 2AB , Urszula Religioni 4DEF , Agnieszka Barańska 5CD , Maria Malm 5CD , Agnieszka Neuman-Podczaska 6DEF , Regis Vaillancourt 2ACDF , Piotr Merks 2AFGDOI: 10.12659/MSM.939841
Med Sci Monit 2023; 29:e939841
Table 2 Data on vaccinations.
Characteristic | N | N=53 |
---|---|---|
53 | ||
Astra | 17 (32.1%) | |
Johnson | 9 (17.0%) | |
Moderna | 4 (7.5%) | |
Pfizer | 23 (43.4%) | |
53 | ||
1 | 13 (24.5%) | |
2 | 39 (73.6%) | |
3 | 1 (1.9%) | |
53 | ||
Yes | 49 (92.5%) | |
No | 4 (7.5%) | |
53 | ||
Median [IQR] | 23.71 [19.86, 26.29] | |
Range | 0.6, 38.0 | |
IQR – interquartile range. |